Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
WARD 32 ONCOLOGY UNIT STUDENT NURSE ORIENTATION PACK WRITTEN BY S.S.N’ANGEE MILNE Contributed S.S.N.ASHLEY CAIRD& PRINTED DECEMBER 2008 DATE FOR REVIEW JULY 2009/ Jan 2015 Updated 18/02/2016 0 Index Welcome to ward 32! p2 Objectives/expectations p2 Introduction p3 Activities to help meet your objectives p4 Areas you may wish to visit p5 Average length of stay p6 Some homework! P7, 8 Cancer glossary, personal dictionary p9, 10 Oncology unit Consultants and cancer specialities p11 Bipsychosocial cancer patient needs p12 Appendix 1 – support process for student nurses p13 Appendix 2 – student placement evaluation p14 1 WELCOME TO WARD 32! The team in Ward 32 would like to welcome you to the Ward. We hope you enjoy your time with us and find it both an interesting and beneficial learning experience. If you are unsure of anything, please do not hesitate to ask questions and if any problems arise, please discuss these as soon as possible with your mentor, associate or SCN Lynne Clarke or SCN Alison Inglis. Visions of Oncology Unit To be a centre of excellence that provides a high standard of evidence based quality care to all patients with cancer. Aims Promote multidisciplinary team working; Promote patient and public involvement in any new developments; Collate patient and carers feedback regarding experiences and strive to improve. OBJECTIVES/EXPECTIONS While we will all work with you to ensure you are aware of the learning opportunities available, staff are aware of how daunting it can be to arrive in such a busy environment. We are here to help facilitate your learning needs and help you to achieve your goals. You will have been assigned a mentor and associate who will be on hand to meet with you and discuss expectations of the placement within the unit. Mentor: Associate Mentor: 2 INTRODUCTION The Oncology Unit is divided into a number of specialised areas which cover all aspects of caring for patients living with cancer in Tayside, Fife, Perth and Angus. These areas within the unit include:The Main Ward:This has 26 beds total: 3 bays (6 beds per bay) and 8 side rooms. The ward provides care for patients receiving a range of radiotherapy (XRT) treatments, symptom control, palliative and end of life care. 5 Day Chemotherapy Unit:Which has 10 beds (5 beds per bay). And 4 day case spaces. Nursing staff administer chemotherapy to cancer patients. These patients may require an overnight stay or longer depending on the regime they are receiving. The Chemotherapy Day Area:Is where patients come in from home to receive chemotherapy and supportive treatments within a friendly, relaxed environment and leave at the end of the day. Out-Patient Clinic:Where medics review outpatients and discuss future planned care and treatments within one of the 5 treatment rooms. Simulator:An area where radiotherapy treatment is planned. Brachytherapy Suite/Selection:A newly refurbished suite situated in the chemotherapy day area. Female patients receive radiotherapy treatment for gynaecological cancer via a sealed source of radiation (brachytherapy). Nurses on the ward care for these patients. Iodine Isolation Room:Again situated within the chemotherapy day area where there are two different types of treatment given. I131 Treatment for thyroid cancer and MIBG treatment for neuroendicrine cancer (hormonal). This is an unsealed source of radiation. Nurses on the ward care for these patients. Radiotherapy Suite:Situated on level 2. An exciting new building where radiotherapy is administered to both IPT ‘s and OPT’s. Ugo Stefani Unit:Clinical Trials Research Centre named after one of Professor Rankin’s patients who kindly donated funds to research and new treatments. 3 Princess Alexandra Unit:-Research offices located at entrance of 5 day chemotherapy unit. Activities to Help Meet Your Objectives Activity Date Completed Introduction to your mentor/associate mentor. Orientation to ward area Fire points and evacuation procedures Explain nurse call system/ emergency call and equipment used Be aware of responsibilities in relation to the following TRUST policies: Infection control (discuss and demonstrate) Health & Safety – Reporting Incidents / I.R.1. Manual Handling Ward Routine / Daily planner Introduction to patients Overview of Nursing Records/ Documentation Location of Trust/ Unit Policies Off duty planning requests Identify P.E.F.(currently awaiting allocation) Sickness Policy Participate in team meetings Communicate with all members of M.D.T. on a daily basis Patient information leaflets (BACUP) 4 AREAS YOU MAY WISH TO VISIT WHILE ON PLACEMENT IN THE ONCOLOGY UNIT Date Achieved The Chemotherapy Five Day Unit …………………. The Chemotherapy Day Area …………………. Out Patient Clinic …………………. Radiotherapy Suite ………………… Simulator (Radiotherapy Planning) …………………. Various Specialist Nurses (Hospital Palliative Care Team, XRT Nurse Etc.) …………………. Clinical Trials Research Nurses/Stefani Unit …………………. The Maggie’s Centre for Cancer Care ………………… Your own specific objectives:- 5 AVERAGE LENGTH OF STAY GUIDE FOR PREDICTING ESTIMATED DATES OF DISCHARGE (EDD) WARD 32 MAIN DIAGNOSIS RELATED SYMPTOM/TREATMENT ESTIMATED LENGTH OF STAY Malignant neoplasm of bronchus or lung dyspnoea pleural effusion infection 5 days 5 days 5 days Malignant neoplasm of ovary ascites pain control infection sub acute obstruction 4 days 4 days 5 days 7-10 days Malignant neoplasm of breast pleural effusion neutropaenic sepsis 5 days 5 days Malignant neoplasm of prostate hemi body irradiation spinal cord compression(SCC) 3 days 7-10 days Malignant neoplasm of oesophagus dysphagia requiring stenting post chemo side effects post radiotherapy side effects 1 day after stent insertion 5 days 5 days Malignant neoplasm of kidney hypocalcaemia 5 days Malignant neoplasm of colon obstruction post chemo side effects 7 days 7 days All tumour types nausea & vomiting 5 days All tumour types anaemia 4 days All tumour types planned radiotherapy number of planned treatments should be known Number of days as per each specific patient plan. e.g. XRT 5# = 5 days 6 Some Homework!!!!!! Briefly what is? Dyspnoea Pleural Effusion Ascites Sub acute Obstruction Neutropaenic Sepsis Hemi body Irradiation SCC Dysphagia Palliative/ End of Life Care 7 More Homework!!!!!! Briefly what is? Basic Cell Structure Carcinogens, what are they? Basic abnormalities within the cancer cell Metastasis 8 CANCER GLOSSARY – www.meds.com/glossary.html A Adenocarcinoma A.F.P. (Alphafetoprotein) Antigen Antineoplastic agent B Benign Growth C Cancer Carcinogen Carcinoma CEA (Carcinoembryonic antigen) Chemotherapy E Effusion Extravasation H Hickman (line) Catheter/Central Line Hodgkin’s Disease I Immunosuppression L Lesion Leukaemia Leucopoenia Lymphocytes Lymph Nodes M Malignant Tumours See Carcinoma. A malignant tumour arising from glandular tissue A tumour maker in the blood Any substance that causes the body to produce normal antibodies A drug that prevents, kills and blocks the growth and spread of cancer cells A swelling or growth that is not cancerous A group of diseases in which malignant cells grow out of control and spread to other parts of the body A substance that causes cancer e.g. nicotine – lung cancer A type of cancer that skirts in the skin or lining of organs. Basal Cell Carcinoma (BCC) – Skin cancer (most common) Squamous Cell Carcinoma (SCC) – Arising from the skin or surfaces of other structures, e.g. mouth/cervix/lungs A blood tumour marker The treatment of cancer with drugs (oral or intravenously) Adjuvant Chemotherapy – Chemotherapy given to kill any remaining cancer cells usually post tumour removal by surgery or radiotherapy A collection of fluid in a body cavity e.g. Pleural Effusion – lungs The leaking of I.V. fluids or medication into the surrounding tissues Aseptic surgically inserted catheter for I.V. medication/close patient monitoring e.g. CVP, antibiotics long term Cancer that affects the lymph nodes = lymphoma Weakening of the immune system, reduced ability to fight infection A lump or abscess maybe caused by injury or disease such as cancer Cancer of the blood. WBC present in blood excessively thus body unable to function correctly Reduction of white blood cells (WBC) WBC that kill viruses and acts as a defence Small oval bodies that contain lymph. First line of defence against infections A tumour made up of cancerous cells of the type that can spread to other 9 Melanoma Metastasize Myeloma Myelosuppression N Neoplasm Neutropaenia Non Hodgkin’s Lymphoma (NHL) P Palliative Treatment Pathological Fracture R Regression S Sarcoma parts of the body A cancer of the pigment forming cells of the skin or retina of the eye A spread from the first cancer site e.g. breast to bone A malignant tumour of the bone marrow associated with the production of abnormal proteins A decrease in the production of RBC, platelets and some WBC by the bone marrow A new growth of tissue or cells, a tumour that is generally malignant A decreased number of WBC (neutrophils) A cancer of the lymphatic system. Relate to Hodgkin’s disease but is made up of different cell types Treatment aimed at the relief of pain and symptoms of disease but not intended to cure (#) Caused by a cancer or some other disease process The shrinkage of a cancer growth A malignant tumour of muscles or connective tissue Personal Oncology Dictionary Word Definition Personal note of common cancer treatment drugs Drug Name Drug Desired Effect Drug Side Effect Use overleaf if required 10 ONCOLOGY UNIT CONSULTANTS AND CANCER SPECIALITIES Head and Neck Gynaelogical/Testes Dr Casasola (RJC) &Melanoma Dr Niblock (PGN) Dr Lord (HKL) (Glioma) Dr Casasola (RJC) Dr Ferguson (MF) Dr Armstrong (SA) Breast Upper G.I. Dr Adamson (DJA) Dr Niblock (PGN) Colorectal Dr Adamson (DJA) Dr Mohanamurali (MM) Lung Dr Scott (AS) Dr Lord (HKL) & XRT Planning Dr Mahanamurali (MM) Dr Sanders (IS) Dr Armstrong (SA) Sarcoma Dr Ferguson (MF) G.U. Dr Polunsamy (SP) Dr Niblock (PGN) Dr Brown (EB) 11 BIOPSYCHOSOCIAL CANCER PATIENT NEEDS Maggie’s Centre Ψ Review Translators S.A.L.T Dermatology McMillan Nurses D.N.’s Day Centre Roxburgh House Support – Nurse Marie Curie Specialists Chemotherapy Nurses X Roads Spiritual Care Hospital Palliative Care Oncology Support Team Dietician / Diabetes P.E.G. (Parenteral Nutrition) Physio / OT S.W.D. Carers Podiatry 12 APPENDIX 1 – SUPPORT PROCESS FOR STUDENT NURSES 13 APPENDIX 2 – STUDENT PLACEMENT EVALUATION Please take a moment of your time to complete this form, as this highlights to us improvements needed to make appropriate changes if necessary. Please be honest and explain your answers. Complete and return prior to end of placement. QUESTION Were you rostered to work with your mentor in week 1? CIRCLE ANSWER YES/NO Was your mentor allocated to you on your first day? YES/NO Were you orientated to the ward on your first day? YES/NO Was the ward routine explained? YES/NO Were you shown and informed about everything in the orientation checklist? YES/NO Did you set objectives and develop a learning contract in the first week? YES/NO Did you feel your mentor fulfilled their role? YES/NO Did you achieve all your personal objectives, if not, why? YES/NO Did you enjoy your placement? Please try to explain. YES/NO Do you feel anything can be done to improve the learning experience? YES/NO At what level do you feel the practical experience and teaching available on the ward is? POOR SATISFACTORY HIGH Were you made to feel part of the multidisciplinary team? YES/NO COMMENTS Any other useful comments Thank you and we all would like to wish you the very best of luck in your nursing career!!! 14